ABBV
AbbVie Inc
264.40$
-0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8% | 33.0% | 27.5% | 35.3% | 41.0% | 40.1% | 38.4% | 40.5% | 43.0% | 42.0% | 33.4% | 31.1% | |
| 3.9% | 3.7% | 4.6% | 5.3% | 5.4% | 6.1% | 14.1% | 15.2% | 14.6% | 16.0% | 14.9% | 13.3% | |
| 1.2% | 1.2% | 1.4% | 1.3% | 1.3% | 1.3% | 1.6% | 1.2% | 1.2% | 1.4% | 1.6% | 1.6% | |
| 8.9% | 4.6% | 6.2% | 6.7% | 20.4% | 14.3% | 13.9% | 7.2% | 4.6% | – | – | – | |
| -3.9% | 2.2% | -6.6% | 0.0% | -3.4% | -4.0% | 0.2% | -2.4% | -0.4% | 5.2% | -4.9% | -3.9% | |
| 3.1% | 2.3% | 1.9% | 1.9% | 1.9% | 1.7% | 1.7% | 1.4% | 1.2% | 1.4% | 1.7% | 2.0% | |
| -4.6% | -56.6% | -23.7% | -1.0% | -3.1% | 1.8% | -82.0% | -4.2% | -1.1% | -3.7% | -37.0% | -10.9% | |
| 13.3% | 14.4% | 14.5% | 14.6% | 17.0% | 19.1% | 16.8% | 16.5% | 17.3% | 19.4% | 19.6% | 19.1% | |
| -3.3% | -33.2% | -23.5% | -5.0% | -36.7% | -1.9% | -2.1% | -1.7% | -2.6% | -3.6% | -3.0% | -1.6% | |
| 0.1% | 71.9% | 21.5% | 0.0% | 9.7% | 77.6% | -5.9% | -15.0% | -21.4% | -7.6% | 13.0% | -0.5% | |
| -16.5% | 25.2% | -15.3% | -19.5% | -44.0% | 56.2% | -25.1% | -33.9% | -42.7% | -31.7% | -9.3% | -20.8% | |
| -6.2% | 0.2% | -12.9% | 14.9% | -6.1% | 98.1% | -68.7% | 2.3% | -0.9% | 6.7% | -12.9% | -0.5% | |
| 14.7% | 30.6% | 25.6% | 33.4% | 39.0% | 38.4% | 36.7% | 39.1% | 41.8% | 40.6% | 31.7% | 29.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.